Careers  |  Sign In  |  Register

Latest in Medical Students

Reuters Health • The Doctor's Channel Daily Newscast

Early oseltamivir use shortens shedding of H1N1 virus

NEW YORK (Reuters Health) – Patients with the H1N1 virus who started oseltamivir in the first 3 days of illness had shorter periods of viral shedding, according to an observational study reported in the April 1st issue of Clinical Infectious Diseases. The data are from the first 70 consecutive patients...

Reuters Health • The Doctor's Channel Daily Newscast

Cladribine and fludarabine equally helpful for progressive CLL

NEW YORK (Reuters Health) - As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to phase III trial results. Purine nucleoside analogs such as cladribine and fludarabine are...

Reuters Health • The Doctor's Channel Daily Newscast

CD68+ macrophages linked to treatment failure in Hodgkin’s lymphoma

NEW YORK (Reuters Health) - A new biomarker - tumor-associated CD68+ macrophages -- predicts poor outcomes in patients with classic Hodgkin's lymphoma, new research indicates. About 20% of patients with Hodgkin's lymphoma die of progressive disease, including about half of patients treated by autologous...